Wei Xu

机构：Shandong University, Shanghai Jiao Tong University, Peking University, Peking University Cancer Hospital, Tianjin Children's Hospital, Shandong Provincial Hospital, Jining First People's Hospital, Institute of Animal Sciences, Jiangsu Province Hospital, Zhejiang University, Nanjing Medical University · ORCID：0000-0002-9725-4335

发表论文 106 篇 · 总被引 1310 次 · h-index 20

代表论文

• Integrative Single-Cell and Spatial Transcriptomics Analysis Reveals ECM-remodeling Cancer-associated Fibroblast-Derived POSTN as a Key Mediator in Pancreatic Ductal Adenocarcinoma Progression (2025 · International Journal of Biological Sciences · 被引 23)
• The efficacy of immunotherapy in non-small cell lung cancer with KRAS mutation: a systematic review and meta-analysis (2024 · Cancer Cell International · 被引 15)
• A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma (2025 · Biomarker Research · 被引 7)
• Serum iron element: A novel biomarker for predicting PD-1 immunotherapy efficacy (2024 · International Immunopharmacology · 被引 5)
• Association Between Pretreatment Blood 25-Hydroxyvitamin D Level and Survival Outcomes in Patients With Clinically Localized Prostate Cancer: An Updated Meta-Analysis (2024 · Nutrition and Cancer · 被引 5)
• Hybrid symbolic regression for data-driven discovery: Governing dimensionless numbers in supercritical heat transfer (2025 · Energy · 被引 4)